Atherogenic Index of Plasma [Log(Triglycerides/Hdl-Cholesterol)]: Theoretical and Practical Implications (Editorial) More Books Like This

High-Density Lipoproteins High-Density Lipoproteins
2011
Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference) Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference)
1998
Comparison of the Relationships Between Serum Apolipoprotein B and Serum Lipid Distributions (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Comparison of the Relationships Between Serum Apolipoprotein B and Serum Lipid Distributions (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2005
Estimating LDL Apob: Infomania Or Clinical Advance?(Editorial) (Clinical Report) Estimating LDL Apob: Infomania Or Clinical Advance?(Editorial) (Clinical Report)
2008
Taq1b Polymorphism of Cholesteryl Ester Transfer Protein (CETP) Gene in Primary Combined Hyperlipidaemia (Report) Taq1b Polymorphism of Cholesteryl Ester Transfer Protein (CETP) Gene in Primary Combined Hyperlipidaemia (Report)
2009
Plasma Paraoxonase Activity in Patients with Systemic Sclerosis. Plasma Paraoxonase Activity in Patients with Systemic Sclerosis.
2009
Influence of Folic Acid on Plasma Homocysteine Levels & Arterial Endothelial Function in Patients with Unstable Angina (Report) Influence of Folic Acid on Plasma Homocysteine Levels & Arterial Endothelial Function in Patients with Unstable Angina (Report)
2009
Applications of Biotechnology in Cardiovascular Therapeutics Applications of Biotechnology in Cardiovascular Therapeutics
2011
Changes in Antioxidant Defense Status in Hypercholesterolemic Rats Treated with Ajuga Iva. Changes in Antioxidant Defense Status in Hypercholesterolemic Rats Treated with Ajuga Iva.
2008
Reviews on New Drug Targets in Age-Related Disorders Reviews on New Drug Targets in Age-Related Disorders
2021
Biochemistry of Apoptosis and Autophagy Biochemistry of Apoptosis and Autophagy
2021
Therapeutic Neovascularization – Quo vadis? Therapeutic Neovascularization – Quo vadis?
2007
Membrane Lipidomics for Personalized Health Membrane Lipidomics for Personalized Health
2015
Human iPS Cells in Disease Modelling Human iPS Cells in Disease Modelling
2016
Sphingolipids and Metabolic Disease Sphingolipids and Metabolic Disease
2011